EFFECTOR Therapeutics Insiders
EFFECTOR Therapeutics employs about 14 people. The company is managed by 9 executives with a total tenure of roughly 33 years, averaging almost 3.0 years of service per executive, having 1.56 employees per reported executive. Recap of EFFECTOR Therapeutics' management performance can provide insight into the venture performance.
| Stephen Worland CEO President CEO |
EFFECTOR |
EFFECTOR Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.8333) % which means that it has lost $0.8333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (9.4656) %, meaning that it generated substantial loss on money invested by shareholders. EFFECTOR Therapeutics' management efficiency ratios could be used to measure how well EFFECTOR Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.EFFECTOR Therapeutics Workforce Comparison
EFFECTOR Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 360. EFFECTOR Therapeutics holds roughly 14.0 in number of employees claiming about 4% of equities under Health Care industry.
EFFECTOR Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EFFECTOR Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on EFFECTOR Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, EFFECTOR Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Presidio Management Group X Llc over six months ago Disposition of 799 shares by Presidio Management Group X Llc of EFFECTOR Therapeutics at 6.695 subject to Rule 16b-3 | ||
Byrnes Michael over six months ago Acquisition by Byrnes Michael of 4524 shares of EFFECTOR Therapeutics at 0.4973 subject to Rule 16b-3 | ||
Ehrlich Christopher B over six months ago Acquisition by Ehrlich Christopher B of 18867 shares of EFFECTOR Therapeutics at 0.55 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Disposition of 33799 shares by Stephen Worland of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Acquisition by Stephen Worland of 33799 shares of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 |
EFFECTOR Therapeutics Notable Stakeholders
An EFFECTOR Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EFFECTOR Therapeutics often face trade-offs trying to please all of them. EFFECTOR Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EFFECTOR Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stephen Worland | President CEO | Profile | |
| Siegfried Reich | CoFounder Advisor | Profile | |
| Mayank MD | Chief Officer | Profile | |
| Michael MBA | Chief Officer | Profile | |
| Alana MBA | Chief Officer | Profile | |
| Premal MD | Chief Officer | Profile | |
| Davide Ruggero | CoFounder Board | Profile | |
| Douglas MD | Chief Officer | Profile | |
| Kevan Shokat | CoFounder Board | Profile |
EFFECTOR Therapeutics Workforce Analysis
Traditionally, organizations such as EFFECTOR Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EFFECTOR Therapeutics within its industry.EFFECTOR Therapeutics Manpower Efficiency
Return on EFFECTOR Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2.6M | |
| Net Loss Per Executive | 4M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in EFFECTOR Pink Sheet
If you are still planning to invest in EFFECTOR Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EFFECTOR Therapeutics' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world |